ZA201805982B - Biomarkers of traumatic brain injury - Google Patents
Biomarkers of traumatic brain injuryInfo
- Publication number
- ZA201805982B ZA201805982B ZA2018/05982A ZA201805982A ZA201805982B ZA 201805982 B ZA201805982 B ZA 201805982B ZA 2018/05982 A ZA2018/05982 A ZA 2018/05982A ZA 201805982 A ZA201805982 A ZA 201805982A ZA 201805982 B ZA201805982 B ZA 201805982B
- Authority
- ZA
- South Africa
- Prior art keywords
- biomarkers
- brain injury
- traumatic brain
- traumatic
- injury
- Prior art date
Links
- 208000030886 Traumatic Brain injury Diseases 0.000 title 1
- 239000000090 biomarker Substances 0.000 title 1
- 230000009529 traumatic brain injury Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/118—Prognosis of disease development
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/158—Expression markers
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/178—Oligonucleotides characterized by their use miRNA, siRNA or ncRNA
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Physics & Mathematics (AREA)
- General Engineering & Computer Science (AREA)
- Pathology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Anesthesiology (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1603967.9A GB201603967D0 (en) | 2016-03-08 | 2016-03-08 | Biomarkers of traumatic brain injury |
| PCT/GB2017/050231 WO2017153710A1 (en) | 2016-03-08 | 2017-01-30 | Biomarkers of traumatic brain injury |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201805982B true ZA201805982B (en) | 2022-01-26 |
Family
ID=55859162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2018/05982A ZA201805982B (en) | 2016-03-08 | 2018-09-06 | Biomarkers of traumatic brain injury |
Country Status (14)
| Country | Link |
|---|---|
| US (5) | US20190085395A1 (enExample) |
| EP (7) | EP3426796B1 (enExample) |
| JP (5) | JP7111619B2 (enExample) |
| KR (4) | KR20240167935A (enExample) |
| CN (4) | CN116004796A (enExample) |
| AU (3) | AU2017231845B2 (enExample) |
| CA (2) | CA3015150A1 (enExample) |
| ES (4) | ES2967073T3 (enExample) |
| GB (1) | GB201603967D0 (enExample) |
| NZ (1) | NZ782016A (enExample) |
| PL (2) | PL3712277T3 (enExample) |
| UA (1) | UA127918C2 (enExample) |
| WO (2) | WO2017153710A1 (enExample) |
| ZA (1) | ZA201805982B (enExample) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3122905B1 (en) | 2014-03-27 | 2020-09-09 | Yale University | Circulating micrornas as biomarkers for endometriosis |
| GB201603967D0 (en) | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| MX2019002425A (es) * | 2016-08-30 | 2019-08-16 | Univ Yale | Micro ácidos ribonucleicos como biomarcadores para la endometriosis. |
| WO2018175941A1 (en) * | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Analysis and prediction of traumatic brain injury and concusion symptoms |
| US11739323B2 (en) * | 2017-06-08 | 2023-08-29 | Temple University-Of The Commonwealth System Of Higher Education | Micro-RNAs as biomarkers for subconcussive and concussive injury and therapeutic applications |
| EP3803416A4 (en) * | 2018-05-31 | 2022-05-18 | Amydis, Inc. | COMPOSITIONS AND METHODS FOR DETECTING BRAIN TRAUMA |
| SG10201807529VA (en) * | 2018-09-03 | 2020-04-29 | Nec Asia Pacific Pte Ltd | Systems and methods for predicting recovery of a patient |
| US11315660B2 (en) | 2018-10-31 | 2022-04-26 | Dot Laboratories, Inc. | Method of detecting and treating endometriosis in a female subject |
| PE20220877A1 (es) * | 2019-02-14 | 2022-05-27 | Marker Diagnostics Uk Ltd | Biomarcadores salivales de lesion cerebral |
| KR102184840B1 (ko) * | 2019-05-20 | 2020-11-30 | 이화여자대학교 산학협력단 | 외상 후 스트레스 장애 진단 또는 예측용 바이오마커 및 그의 용도 |
| US11965879B2 (en) * | 2019-08-23 | 2024-04-23 | Mcmaster University | Method for diagnosing and assessing endometriosis |
| KR102272915B1 (ko) | 2019-09-27 | 2021-07-06 | 주식회사 이지다이아텍 | 새로운 외상성 뇌손상 및 감염병 poct 진단시스템 |
| CN110684835A (zh) * | 2019-10-12 | 2020-01-14 | 山东大学齐鲁医院 | miR-21在诊治蛛网膜下腔出血中的应用 |
| CN111419866A (zh) * | 2020-03-02 | 2020-07-17 | 南通大学 | miR-29a-3p在制备治疗周围神经损伤药物中的应用 |
| US12157918B2 (en) * | 2020-09-04 | 2024-12-03 | University Of Kentucky Research Foundation | Clinical assessment of cerebral vasospasm risk following aneurysmal subarachnoid hemorrhage |
| IL307369A (en) | 2021-04-02 | 2023-11-01 | Marker Holdings Ag | Biomarkers of muscle and skeletal injury |
| CN116219019A (zh) * | 2023-03-02 | 2023-06-06 | 圣湘生物科技股份有限公司 | 一种用于结直肠癌诊断的microRNA标志物组合物及检测试剂、检测试剂盒 |
| WO2024242411A1 (ko) | 2023-05-19 | 2024-11-28 | 주식회사 이지다이아텍 | 자동 항체 커플링 및 이를 확인하는 장치 |
| WO2025039033A1 (en) * | 2023-08-21 | 2025-02-27 | Glia Diagnostics Pty Ltd | Methods and reagents for diagnosis and/or prognosis of traumatic brain injury |
Family Cites Families (31)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH31414A (en) | 1994-02-24 | 1998-10-29 | Boehringer Ingelheim Int | Method of diagnosing cancer precancerous state, orsusceptibility to other forms of diseases by anal ysis of irf-1 specific rna in biopsy samples. |
| WO1999033018A1 (de) | 1997-12-18 | 1999-07-01 | Infineon Technologies Ag | Vorrichtung zur bilderfassung |
| RU66524U1 (ru) | 2007-05-03 | 2007-09-10 | Федор Андреевич Егоров | Сооружение, в котором обеспечена возможность комплексного мониторинга сооружения |
| CN101424640B (zh) | 2007-11-02 | 2012-07-25 | 江苏命码生物科技有限公司 | 血清中微小核糖核酸的检测方法和用于检测的试剂盒、生物芯片及其制作和应用方法 |
| DE102008017652A1 (de) | 2008-04-04 | 2009-10-08 | Leonhard Kurz Stiftung & Co. Kg | Sicherheitselement sowie Verfahren zur Herstellung eines Sicherheitselements |
| EP2336353A1 (en) | 2009-12-17 | 2011-06-22 | febit holding GmbH | miRNA fingerprints in the diagnosis of diseases |
| HUE040281T2 (hu) * | 2009-09-14 | 2019-03-28 | Banyan Biomarkers Inc | Autoantitest markerek traumás agysérülés diagnózisára |
| RU93660U1 (ru) | 2010-02-08 | 2010-05-10 | Государственное образовательное учреждение высшего профессионального образования "Ростовский государственный медицинский университет Федерального агентства по здравоохранению и социальному развитию" (ГОУ ВПО "РостГМУ Росздрава") | Тест-полоска для диагностики нефропатии |
| CN103237901B (zh) * | 2010-03-01 | 2016-08-03 | 卡里斯生命科学瑞士控股有限责任公司 | 用于治疗诊断的生物标志物 |
| WO2013159091A2 (en) * | 2012-04-20 | 2013-10-24 | Aptamir Therapeutics, Inc. | Mirna modulators of thermogenesis |
| US20150203916A1 (en) | 2012-06-27 | 2015-07-23 | Music Foundation For Research Development | Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm |
| GB201223243D0 (en) * | 2012-12-21 | 2013-02-06 | King S College London | Detection method |
| EP3418430B1 (en) | 2013-03-15 | 2023-03-29 | The Trustees of the University of Pennsylvania | Blood biomarkers that predict persistent cognitive dysfunction after concussion |
| US9890428B2 (en) * | 2013-05-14 | 2018-02-13 | Ohio State Innovation Foundation | MiRNA biomarkers for radiation biodosimetry |
| US9434945B2 (en) * | 2013-08-02 | 2016-09-06 | University Of Maryland, Baltimore | Use of miR-23a-3p and/or miR-27a-3p mimics as therapeutic agents for inhibition of neuronal apoptosis following brain injury |
| CN103667445A (zh) * | 2013-10-16 | 2014-03-26 | 石磊 | 一种脑梗塞早期诊断标志物及其应用 |
| WO2015073972A1 (en) * | 2013-11-18 | 2015-05-21 | Diamir, Llc | METHODS OF USING mIRNAs FROM BODILY FLUIDS FOR DETECTION AND MONITORING OF PARKINSON'S DISEASE (PD) |
| WO2015128192A1 (en) * | 2014-02-26 | 2015-09-03 | Koninklijke Philips N.V. | Light reflectance based detection |
| WO2015134551A1 (en) * | 2014-03-03 | 2015-09-11 | Banyan Biomarkers, Inc. | Micro rna markers for diagnosis of a neurological condition |
| US9605315B2 (en) * | 2014-03-26 | 2017-03-28 | The University Of Montana | Detection of traumatic brain injury |
| WO2015153864A2 (en) | 2014-04-02 | 2015-10-08 | Hopkins Patricia T | Methods for treating inflammatory conditions |
| WO2015164431A2 (en) * | 2014-04-22 | 2015-10-29 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Methods, processes, devices and kits for the measurement of post traumatic stress disorder microrna markers |
| WO2015196191A1 (en) * | 2014-06-20 | 2015-12-23 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for traumatic brain injury and methods of use thereof |
| ES2558262B2 (es) | 2014-08-01 | 2016-07-14 | Universidad Católica De Valencia "San Vicente Mártir" | Método de diagnóstico de fibromialgia basado en microRNAs |
| CN104293791B (zh) * | 2014-10-22 | 2018-01-12 | 首都医科大学附属北京友谊医院 | miR‑200b在制备Rac‑1蛋白表达抑制剂中的新用途 |
| CA2993989A1 (en) * | 2015-07-29 | 2017-02-02 | The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. | Microrna biomarkers for traumatic brain injury and methods of use thereof |
| WO2017044650A1 (en) | 2015-09-08 | 2017-03-16 | The Translational Genomics Research Institute | Biomarkers and methods of diagnosing and prognosing mild traumatic brain injuries |
| GB201603967D0 (en) | 2016-03-08 | 2016-04-20 | Univ Birmingham | Biomarkers of traumatic brain injury |
| WO2018175941A1 (en) | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Analysis and prediction of traumatic brain injury and concusion symptoms |
| WO2018175422A1 (en) | 2017-03-23 | 2018-09-27 | Quadrant Biosciences Inc. | Method for diagnosing or monitoring conditions characterized by abnormal temporal variations method of normalizing epigenetic data to compensate for temporal variations |
| PE20220877A1 (es) | 2019-02-14 | 2022-05-27 | Marker Diagnostics Uk Ltd | Biomarcadores salivales de lesion cerebral |
-
2016
- 2016-03-08 GB GBGB1603967.9A patent/GB201603967D0/en not_active Ceased
-
2017
- 2017-01-30 US US16/083,178 patent/US20190085395A1/en not_active Abandoned
- 2017-01-30 UA UAA201809265A patent/UA127918C2/uk unknown
- 2017-01-30 KR KR1020247037409A patent/KR20240167935A/ko active Pending
- 2017-01-30 PL PL20169635.8T patent/PL3712277T3/pl unknown
- 2017-01-30 EP EP17703217.4A patent/EP3426796B1/en active Active
- 2017-01-30 CN CN202211408247.8A patent/CN116004796A/zh active Pending
- 2017-01-30 ES ES17703217T patent/ES2967073T3/es active Active
- 2017-01-30 AU AU2017231845A patent/AU2017231845B2/en active Active
- 2017-01-30 JP JP2018546868A patent/JP7111619B2/ja active Active
- 2017-01-30 CN CN201780015193.XA patent/CN109415769B/zh active Active
- 2017-01-30 EP EP20169635.8A patent/EP3712277B1/en active Active
- 2017-01-30 ES ES20169635T patent/ES2987237T3/es active Active
- 2017-01-30 WO PCT/GB2017/050231 patent/WO2017153710A1/en not_active Ceased
- 2017-01-30 KR KR1020187026295A patent/KR102729795B1/ko active Active
- 2017-01-30 CA CA3015150A patent/CA3015150A1/en active Pending
- 2017-01-30 EP EP24174972.0A patent/EP4403649A3/en active Pending
- 2017-01-30 NZ NZ782016A patent/NZ782016A/en unknown
- 2017-12-22 EP EP17822770.8A patent/EP3574117B1/en active Active
- 2017-12-22 EP EP25164531.3A patent/EP4582559A3/en active Pending
- 2017-12-22 JP JP2019539924A patent/JP7132224B2/ja active Active
- 2017-12-22 WO PCT/GB2017/053887 patent/WO2018138468A1/en not_active Ceased
- 2017-12-22 ES ES20169652T patent/ES2965297T3/es active Active
- 2017-12-22 CA CA3050996A patent/CA3050996A1/en active Pending
- 2017-12-22 CN CN201780084939.2A patent/CN110291210B/zh not_active Expired - Fee Related
- 2017-12-22 ES ES23184544T patent/ES3032995T3/es active Active
- 2017-12-22 EP EP20169652.3A patent/EP3712280B8/en active Active
- 2017-12-22 PL PL23184544.7T patent/PL4257705T3/pl unknown
- 2017-12-22 EP EP23184544.7A patent/EP4257705B1/en active Active
- 2017-12-22 US US15/852,128 patent/US10563262B2/en active Active
- 2017-12-22 KR KR1020197022615A patent/KR102618993B1/ko active Active
- 2017-12-22 KR KR1020237044544A patent/KR20240011189A/ko active Pending
- 2017-12-22 CN CN202410665501.5A patent/CN118441040A/zh active Pending
-
2018
- 2018-09-06 ZA ZA2018/05982A patent/ZA201805982B/en unknown
-
2019
- 2019-12-31 US US16/732,254 patent/US11414705B2/en active Active
-
2022
- 2022-07-21 JP JP2022116002A patent/JP7413455B2/ja active Active
- 2022-07-28 US US17/876,472 patent/US12467095B2/en active Active
- 2022-09-08 US US17/940,988 patent/US20230313300A1/en active Pending
-
2023
- 2023-12-13 AU AU2023282212A patent/AU2023282212B2/en active Active
- 2023-12-27 JP JP2023220147A patent/JP7654769B2/ja active Active
-
2025
- 2025-03-19 JP JP2025044721A patent/JP2025098112A/ja active Pending
- 2025-11-05 AU AU2025263788A patent/AU2025263788A1/en active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA201805982B (en) | Biomarkers of traumatic brain injury | |
| IL267934A (en) | Glyceryl 3-hydroxybururates Traumatic brain injury | |
| IL285151B1 (en) | Methods for the treatment of fgf21-related disorders | |
| ZA201803985B (en) | Traumatic brain injury protection devices | |
| IL259996A (en) | Combinations for cancer treatment | |
| SMT202100115T1 (it) | Combinazioni di inibitori di fgfr e cmet per il trattamento del cancro | |
| PL3453721T3 (pl) | Sposób wytwarzania aneksyny v | |
| SG11201707332XA (en) | Detection of brain injury | |
| IL251262A0 (en) | Methods for treating traumatic brain injury | |
| IL269409A (en) | Combinations of chk1- and wee1 - inhibitors | |
| IL257908A (en) | Methods for the treatment of epilepsy | |
| ZA201706282B (en) | Solid forms of menaquinols | |
| GB201607388D0 (en) | Treatment of impulsivity-related disorders | |
| ZA201707704B (en) | Production of vcl4 | |
| ZA201606921B (en) | Use of xanthophylls for the treatment of cancers | |
| GB201522618D0 (en) | Methods of screening | |
| GB201600964D0 (en) | Determination of vehicle capabilities | |
| GB201503004D0 (en) | Apparatus for altering the mood of an individual | |
| HK40114664A (zh) | 创伤性脑损伤的生物标志物 | |
| EP3280434A4 (en) | Methods of treating a traumatic brain injury | |
| GB201512139D0 (en) | Methods of treatment | |
| GB201721386D0 (en) | Chrondogy of time-wave | |
| GB201602784D0 (en) | New treatment of CFTR-related disorders | |
| GB201512057D0 (en) | In-vitro charaterisation of analytes | |
| GB201607438D0 (en) | New use of pemirolast |